Introduction: In this study, we aimed to assess the relationship of cardiac and hepatic T2* magnetic resonance imaging (MRI) values as a gold standard for detecting iron overload with serum ferritin level, heart function, and liver enzymes as alternative diagnostic methods. Methods: A total 58 patients with beta-thalassemia major who were all transfusion dependent were evaluated for the study. T2* MRI of heart and liver, echocardiography, serum ferritin level, and liver enzymes measurement were performed. The relationship between T2* MRI findings and other assessments were examined. Cardiac and hepatic T2* findings were categorized as normal, mild, moderate, and severe iron overload. Results: 22% and 11% of the patients were suffering from ...
Background: The use of magnetic resonance imaging (MRI) to detect organ-specific iron overload is b...
Thalassemia is a genetic disease caused by disruption of globin chain synthesis leading to severe an...
Cardiac involvement in patients with thalassemia intermedia (TI) is characterized by a high-output s...
AbstractPatients with chronic hemolytic anemia like thalassemia and sickle cell anemia need repeated...
Background: Cardiac failure secondary to transfusional iron overload is the most common cause of dea...
Introduction: Cardiac complications are the leading cause of death in thalassemia patients. It is as...
Objective This study was performed to assess cardiac and hepatic iron overload in young patients wit...
Purpose: This study aimed to evaluate iron levels in cardiac and hepatic tissues using magnetic reso...
Objectives: To evaluate the use of magnetic resonance imaging inpatients with β-thalassemia and to c...
Abstract Background Thalassemia is the most prevalent single-gene disorder. Myocardial and hepatic i...
Background Routine blood transfusions and increased intestinal iron absorption lead to iron accumula...
AbstractPurposeWe report the results of combining cardiac and hepatic MRI in the same examination to...
Background: routine blood transfusion in transfusion-dependent-thalassemia (TDT) causes iron accumul...
Thalassemia intermedia is a highly diverse group of thalassemia syndromes associated with anemia and...
Background: Cardiac iron toxicity is a major cause of mortality in transfusion-dependent beta-thalas...
Background: The use of magnetic resonance imaging (MRI) to detect organ-specific iron overload is b...
Thalassemia is a genetic disease caused by disruption of globin chain synthesis leading to severe an...
Cardiac involvement in patients with thalassemia intermedia (TI) is characterized by a high-output s...
AbstractPatients with chronic hemolytic anemia like thalassemia and sickle cell anemia need repeated...
Background: Cardiac failure secondary to transfusional iron overload is the most common cause of dea...
Introduction: Cardiac complications are the leading cause of death in thalassemia patients. It is as...
Objective This study was performed to assess cardiac and hepatic iron overload in young patients wit...
Purpose: This study aimed to evaluate iron levels in cardiac and hepatic tissues using magnetic reso...
Objectives: To evaluate the use of magnetic resonance imaging inpatients with β-thalassemia and to c...
Abstract Background Thalassemia is the most prevalent single-gene disorder. Myocardial and hepatic i...
Background Routine blood transfusions and increased intestinal iron absorption lead to iron accumula...
AbstractPurposeWe report the results of combining cardiac and hepatic MRI in the same examination to...
Background: routine blood transfusion in transfusion-dependent-thalassemia (TDT) causes iron accumul...
Thalassemia intermedia is a highly diverse group of thalassemia syndromes associated with anemia and...
Background: Cardiac iron toxicity is a major cause of mortality in transfusion-dependent beta-thalas...
Background: The use of magnetic resonance imaging (MRI) to detect organ-specific iron overload is b...
Thalassemia is a genetic disease caused by disruption of globin chain synthesis leading to severe an...
Cardiac involvement in patients with thalassemia intermedia (TI) is characterized by a high-output s...